Yen‐Ming Hsu

3.9k total citations · 2 hit papers
36 papers, 3.1k citations indexed

About

Yen‐Ming Hsu is a scholar working on Immunology, Molecular Biology and Cancer Research. According to data from OpenAlex, Yen‐Ming Hsu has authored 36 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 12 papers in Molecular Biology and 10 papers in Cancer Research. Recurrent topics in Yen‐Ming Hsu's work include T-cell and B-cell Immunology (16 papers), Immune Cell Function and Interaction (11 papers) and Immunotherapy and Immune Responses (8 papers). Yen‐Ming Hsu is often cited by papers focused on T-cell and B-cell Immunology (16 papers), Immune Cell Function and Interaction (11 papers) and Immunotherapy and Immune Responses (8 papers). Yen‐Ming Hsu collaborates with scholars based in United States, Switzerland and Germany. Yen‐Ming Hsu's co-authors include Christopher D. Benjamin, Roy R. Lobb, Theresa M. Palabrica, Mark Aronovitz, Bruce Furie, Barbara C. Furie, Yves Chicheportiche, Haoda Xu, Jeffrey L. Browning and Hamish S. Scott and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Yen‐Ming Hsu

35 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets

1992 661 citations Theresa M. Palabrica, Roy R. Lobb et al. Nature profile →
TWEAK, a New Secreted Ligand in the Tumor Necrosis Factor Family That Weakly Induces Apoptosis

1997 563 citations Yves Chicheportiche, P Bourdon et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yen‐Ming Hsu United States	24	1.5k	1.1k	799	491	408	36	3.1k
J D Griffin United States	32	1.5k 1.0×	1.3k 1.1×	347 0.4×	945 1.9×	420 1.0×	47	3.7k
Roy A. Fava United States	24	1.6k 1.1×	1.5k 1.4×	383 0.5×	232 0.5×	508 1.2×	35	4.0k
Ian K. Campbell Australia	28	1.6k 1.1×	943 0.8×	571 0.7×	325 0.7×	507 1.2×	40	3.6k
Françoise Porteu France	26	887 0.6×	1.3k 1.1×	272 0.3×	603 1.2×	282 0.7×	51	2.6k
Ann Ager United Kingdom	38	2.3k 1.5×	1.3k 1.2×	410 0.5×	378 0.8×	1.1k 2.8×	89	4.3k
Maria Vincenza Carriero Italy	34	951 0.6×	1.5k 1.3×	1.4k 1.7×	402 0.8×	562 1.4×	76	3.8k
M. Asif Amin United States	32	1.0k 0.7×	1.2k 1.1×	362 0.5×	199 0.4×	314 0.8×	61	2.8k
F W Luscinskas United States	9	1.4k 1.0×	921 0.8×	270 0.3×	234 0.5×	569 1.4×	12	2.6k
J M Munro United States	19	1.7k 1.1×	907 0.8×	276 0.3×	420 0.9×	1.6k 4.0×	28	3.4k
Hong Ji China	21	1.9k 1.2×	1.8k 1.6×	300 0.4×	301 0.6×	362 0.9×	35	4.1k

Countries citing papers authored by Yen‐Ming Hsu

Since Specialization

Citations

This map shows the geographic impact of Yen‐Ming Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yen‐Ming Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yen‐Ming Hsu more than expected).

Fields of papers citing papers by Yen‐Ming Hsu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yen‐Ming Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yen‐Ming Hsu. The network helps show where Yen‐Ming Hsu may publish in the future.

Co-authorship network of co-authors of Yen‐Ming Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Yen‐Ming Hsu. A scholar is included among the top collaborators of Yen‐Ming Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yen‐Ming Hsu. Yen‐Ming Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sahbaie, Peyman, et al.. (2025). Blockade of IgG Fc receptors reduces pain after intervertebral disc injury. Pharmacological Reports. 77(3). 809–816. 1 indexed citations

Dutta, Sanjucta, Ai‐ris Y. Collier, Jeng-Shin Lee, et al.. (2022). Pan-neutralizing, germline-encoded antibodies against SARS-CoV-2: Addressing the long-term problem of escape variants. Frontiers in Immunology. 13. 1032574–1032574. 3 indexed citations

Pelletier, Marc R., Jixin Ding, Yen‐Ming Hsu, et al.. (2011). Aberrant Expression of Functional BAFF-System Receptors by Malignant B-Cell Precursors Impacts Leukemia Cell Survival. PLoS ONE. 6(6). e20787–e20787. 38 indexed citations

Michaelson, Jennifer S., Aldo Amatucci, Rebecca K. Kelly, et al.. (2011). Development of an Fn14 agonistic antibody as an anti-tumor agent. mAbs. 3(4). 362–375. 38 indexed citations

Hsu, Yen‐Ming, Melanie L. Conrad, Gerard R. Majeau, et al.. (2010). Antagonism of TIM-1 blocks the development of disease in a humanized mouse model of allergic asthma. Journal of Clinical Investigation. 120(8). 2767–2781. 34 indexed citations

Kang, Yoon‐Joong, et al.. (2009). An active CD8α/pMHCI interaction is required for CD8 single positive thymocyte differentiation. European Journal of Immunology. 40(3). 836–848. 2 indexed citations

Chang, Hsiu‐Ching, Kemin Tan, & Yen‐Ming Hsu. (2006). CD8αβ Has Two Distinct Binding Modes of Interaction with Peptide-Major Histocompatibility Complex Class I. Journal of Biological Chemistry. 281(38). 28090–28096. 13 indexed citations

Michaelson, Jennifer S., Beth Browning, Timothy S. Zheng, et al.. (2005). Tweak induces mammary epithelial branching morphogenesis. Oncogene. 24(16). 2613–2624. 73 indexed citations

Kalled, Susan L., Christine Ambrose, & Yen‐Ming Hsu. (2004). The Biochemistry and Biology of BAFF, APRIL and Their Receptors. PubMed. 8. 206–242. 63 indexed citations

10.

Pelletier, Marc R., Jeffrey S. Thompson, Fang Qian, et al.. (2003). Comparison of Soluble Decoy IgG Fusion Proteins of BAFF-R and BCMA as Antagonists for BAFF. Journal of Biological Chemistry. 278(35). 33127–33133. 79 indexed citations

11.

Schneider, Pascal, Dian L. Olson, Aubry Tardivel, et al.. (2003). Identification of a New Murine Tumor Necrosis Factor Receptor Locus That Contains Two Novel Murine Receptors for Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL). Journal of Biological Chemistry. 278(7). 5444–5454. 101 indexed citations

12.

Brickelmaier, Margot, Gerard R. Majeau, Zhifang Li, et al.. (2002). Alefacept, an Immunomodulatory Recombinant LFA-3/IgG1 Fusion Protein, Induces CD16 Signaling and CD2/CD16-Dependent Apoptosis of CD2+ Cells. The Journal of Immunology. 168(9). 4462–4471. 99 indexed citations

13.

Karpusas, Michael, Janine Ferrant, Christopher D. Benjamin, et al.. (2001). Structure of CD40 Ligand in Complex with the Fab Fragment of a Neutralizing Humanized Antibody. Structure. 9(4). 321–329. 41 indexed citations

14.

Su, Lihe, Ellen A. Garber, & Yen‐Ming Hsu. (2001). CD154 Variant Lacking Tumor Necrosis Factor Homologous Domain Inhibits Cell Surface Expression of Wild-type Protein. Journal of Biological Chemistry. 276(3). 1673–1676. 3 indexed citations

15.

Garber, Ellen A., et al.. (1999). CD154 Variants Associated with Hyper-IgM Syndrome Can Form Oligomers and Trigger CD40-mediated Signals. Journal of Biological Chemistry. 274(47). 33545–33550. 20 indexed citations

16.

Singh, Juswinder, Ellen A. Garber, Herman van Vlijmen, et al.. (1998). The role of polar interactions in the molecular recognition of CD40L with its receptor CD40. Protein Science. 7(5). 1124–1135. 60 indexed citations

17.

Hsu, Yen‐Ming, et al.. (1997). Heteromultimeric Complexes of CD40 Ligand Are Present on the Cell Surface of Human T Lymphocytes. Journal of Biological Chemistry. 272(2). 911–915. 47 indexed citations

18.

Chicheportiche, Yves, P Bourdon, Haoda Xu, et al.. (1997). TWEAK, a New Secreted Ligand in the Tumor Necrosis Factor Family That Weakly Induces Apoptosis. Journal of Biological Chemistry. 272(51). 32401–32410. 563 indexed citations breakdown →

19.

Karpusas, Michael, Yen‐Ming Hsu, Jia‐Huai Wang, et al.. (1995). 2 å crystal structure of an extracellular fragment of human CD40 ligand. Structure. 3(10). 1031–1039. 195 indexed citations

20.

Palabrica, Theresa M., Roy R. Lobb, Barbara C. Furie, et al.. (1992). Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature. 359(6398). 848–851. 661 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact